![Robert Cuthbertson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 6 M $ in data 30/06/2026
Attualmente, Andrew Cuthbertson occupa la posizione di Chief Scientific Officer & Executive Director presso CSL Ltd. e Chief Scientific Officer di CSL Behring LLC (una filiale di CSL Ltd.). Fa anche parte del consiglio di amministrazione di CSL Innovation Pty Ltd., Centre for Eye Research Australia e Grattan Institute ed è membro del Consiglio dell'Università di Melbourne. Andrew Cuthbertson ha precedentemente occupato la posizione di Senior Scientist presso Genentech, Inc.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
CSL LIMITED 0,01% | 17/02/2026 | 71.128 ( 0,01% ) | 6 M $ | 30/06/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| ZENYTH THERAPEUTICS LIMITED | Direttore/Membro del Consiglio | - |
| CSL LIMITED | Direttore/Membro del Consiglio | 17/10/2018 |
CSL Behring LLC
 CSL Behring LLC BiotechnologyHealth Technology Manufactures and markets plasma protein products | Direttore/Membro del Consiglio | 01/01/2018 |
University of Melbourne
 University of Melbourne Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01/01/2016 |
Centre for Eye Research Australia
 Centre for Eye Research Australia General GovernmentGovernment Eliminates vision loss and blindness | Direttore/Membro del Consiglio | 01/03/2017 |
Grattan Institute
 Grattan Institute Miscellaneous Commercial ServicesCommercial Services Develops public policy programs | Direttore/Membro del Consiglio | 01/01/2019 |
| Società | Posizione | Fine |
|---|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Corporate Officer/Principal | 01/01/1997 |
National Institutes of Health
 National Institutes of Health General GovernmentGovernment Engages in the improvement of health and saving lives | Corporate Officer/Principal | - |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 8 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
CSL Innovation Pty Ltd.
 CSL Innovation Pty Ltd. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
CSL Ltd.
 CSL Ltd. BiotechnologyHealth Technology Develops and manufactures medicines that treat people with rare and serious diseases | Health Technology |
University of Melbourne
University of Melbourne Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
National Institutes of Health
National Institutes of Health General GovernmentGovernment Engages in the improvement of health and saving lives | Government |
CSL Behring LLC
CSL Behring LLC BiotechnologyHealth Technology Manufactures and markets plasma protein products | Health Technology |
Centre for Eye Research Australia
Centre for Eye Research Australia General GovernmentGovernment Eliminates vision loss and blindness | Government |
Grattan Institute
Grattan Institute Miscellaneous Commercial ServicesCommercial Services Develops public policy programs | Commercial Services |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
